APAC Dental Biomaterials Market

APAC Dental Biomaterials Market Size (2022 to 2027)

The size of the APAC dental biomaterials market was valued at USD 2 billion in 2022, and this value is forecasted to reach USD 3.09 billion by 2027, growing at a CAGR of 9.06% from 2022 to 2027.

Dental biomaterials are biocompatible synthetic materials and natural tissues to treat tooth decay, damage, and fractures. The market is expected to be driven by the factors such as the increasing prevalence of dental disorders and the growing awareness. The rising population is the major contributor to the market since the elderly population is more prone to numerous oral ailments. For example, rising age is typically connected with higher rates of edentulism. Furthermore, according to the American Association of Oral and Maxillofacial Surgeons, 69 percent of adults aged 35 to 44 have lost at least one permanent tooth due to an accident, tooth decay, gum disease, or failed root canal therapy.

In addition, the initiatives taken by the government and non-government organizations for creating awareness among the people across the through medical tourisms are positively influencing the market growth.  The increasing investments in research and the development of healthcare infrastructure provide new market entrants, and the growing adoption of innovative dental products and the technological advancements in the healthcare sector is boosting the market growth. The major companies in the region are introducing advanced dental products to meet the needs of the consumers. 

Furthermore, to gain a competitive advantage over the market players, the key players are implementing various market strategies such as partnerships, mergers, and acquisitions, which further strengthens the regional market growth. 

However, stringent regulatory and clinical processes are expected to hinder the market growth during the forecast period. 

This report on the APAC dental biomaterials market has been segmented and sub-segmented into the following categories.

By Type:

• Metallic Biomaterials
  • Titanium
  • Stainless Steel
  • Chromium Alloys
  • Others
• Ceramic Biomaterials
• Polymeric Biomaterials
• Metal-Ceramic Biomaterials
• Natural Biomaterials
• Composites Biomaterials

By Application:

• Implantology
• Orthodontics
• Prosthodontics

By End-User:

• Dental Implant and Prosthetic Manufacturers
• Dental Laboratories
• Dental Hospitals & Clinics
• Dental Academics & Research Institutes

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

The Asia Pacific is one of the fastest-growing regions globally in the dental biomaterials market over the forecast period. Therefore, the market is anticipated to register significant growth during the forecast period. The regional market growth is attributed to the developing healthcare sector, growing population, and favorable reimbursement policies. In addition, emerging countries such as China, Japan, and India are expanding the APAC regional market growth with a significant market share.

Regionally, China accounted for the largest share of the APAC dental biomaterials market in 2020, and it is anticipated to register a predominant share during the forecast period. The factors such as technological advancements in the healthcare sector, high healthcare spending growing investments, and the presence of local market players are propelling the market growth.

The Japanese dental biomaterials market is estimated to witness a healthy CAGR during the forecast period. This is because Japan has seen the adoption of technological advancements in the healthcare sector, increasing disposable income, and the growing construction activities of hospitals with the latest equipment.

India has been one of the fastest-growing countries in the Asia Pacific. As a result, the market is likely to record a substantial share during the forecast period. The improving healthcare sector, growing geriatric population, and high prevalence of dental disorders contribute to market growth. In addition, the initiatives and increasing government support through investments are encouraging market growth. 

On the other hand, the Dental biomaterial market in South Korea is projected to have considerable growth opportunities in the coming years. Evolving healthcare sectors, growing awareness, the new product launches in the market are expanding the market growth. In addition, the increased demand for biocompatibility materials due to environmental safety concerns is expected to accelerate the expansion of the dental consumables market.

KEY MARKET PLAYERS:

Straumann Holding AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Carpenter Technology Corporation, Kuraray Co., Ltd., and Henry Schein, Inc. are some of the notable players in the APAC dental biomaterials market.